137 related articles for article (PubMed ID: 15196758)
1. Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial.
Malcolm RK; McCullagh SD; Woolfson AD; Gorman SP; Jones DS; Cuddy J
J Control Release; 2004 Jun; 97(2):313-20. PubMed ID: 15196758
[TBL] [Abstract][Full Text] [Related]
2. Persistence of antimicrobial activity through sustained release of triclosan from pegylated silicone elastomers.
McBride MC; Karl Malcolm R; David Woolfson A; Gorman SP
Biomaterials; 2009 Dec; 30(35):6739-47. PubMed ID: 19765822
[TBL] [Abstract][Full Text] [Related]
3. Experimental design for optimizing drug release from silicone elastomer matrix and investigation of transdermal drug delivery.
Snorradóttir BS; Gudnason PI; Thorsteinsson F; Másson M
Eur J Pharm Sci; 2011 Apr; 42(5):559-67. PubMed ID: 21371556
[TBL] [Abstract][Full Text] [Related]
4. Chitosan inserts for periodontitis: influence of drug loading, plasticizer and crosslinking on in vitro metronidazole release.
Barat R; Srinatha A; Pandit JK; Anupurba S; Mittal N
Acta Pharm; 2007 Dec; 57(4):469-77. PubMed ID: 18165190
[TBL] [Abstract][Full Text] [Related]
5. Release of anti-inflammatory drugs from a silicone elastomer matrix system.
Snorradóttir BS; Gudnason PI; Scheving R; Thorsteinsson F; Másson M
Pharmazie; 2009 Jan; 64(1):19-25. PubMed ID: 19216226
[TBL] [Abstract][Full Text] [Related]
6. Regulation of proxyphylline's release from silicone rubber matrices by the use of osmotically active excipients and a multi-layer system.
Soulas DN; Papadokostaki KG
Int J Pharm; 2011 Apr; 408(1-2):120-9. PubMed ID: 21335074
[TBL] [Abstract][Full Text] [Related]
7. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
[TBL] [Abstract][Full Text] [Related]
8. Psyllium and copolymers of 2-hydroxylethylmethacrylate and acrylamide-based novel devices for the use in colon specific antibiotic drug delivery.
Singh B; Chauhan N; Kumar S; Bala R
Int J Pharm; 2008 Mar; 352(1-2):74-80. PubMed ID: 18055144
[TBL] [Abstract][Full Text] [Related]
9. High speed DSC (hyper-DSC) as a tool to measure the solubility of a drug within a solid or semi-solid matrix.
Gramaglia D; Conway BR; Kett VL; Malcolm RK; Batchelor HK
Int J Pharm; 2005 Sep; 301(1-2):1-5. PubMed ID: 16061335
[TBL] [Abstract][Full Text] [Related]
10. Modeling a system of phosphated cross-linked high amylose for controlled drug release. Part 2: physical parameters, cross-linking degrees and drug delivery relationships.
Cury BS; Castro AD; Klein SI; Evangelista RC
Int J Pharm; 2009 Apr; 371(1-2):8-15. PubMed ID: 19124066
[TBL] [Abstract][Full Text] [Related]
11. In-vitro controlled release of doxorubicin from silica xerogels.
Prokopowicz M
J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
[TBL] [Abstract][Full Text] [Related]
12. Proxyphylline release kinetics from symmetrical three-layer silicone rubber matrices: effect of different excipients in the outer rate-controlling layers.
Soulas DN; Sanopoulou M; Papadokostaki KG
Int J Pharm; 2012 May; 427(2):192-200. PubMed ID: 22330934
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles.
Sairam M; Babu VR; Vijaya B; Naidu K; Aminabhavi TM
Int J Pharm; 2006 Aug; 320(1-2):131-6. PubMed ID: 16766148
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of drugs from multi-component biomaterials.
Zalfen AM; Nizet D; Jérôme C; Jérôme R; Frankenne F; Foidart JM; Maquet V; Lecomte F; Hubert P; Evrard B
Acta Biomater; 2008 Nov; 4(6):1788-96. PubMed ID: 18583206
[TBL] [Abstract][Full Text] [Related]
15. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.
Malcolm RK; Woolfson AD; Toner CF; Morrow RJ; McCullagh SD
J Antimicrob Chemother; 2005 Nov; 56(5):954-6. PubMed ID: 16155060
[TBL] [Abstract][Full Text] [Related]
16. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
[TBL] [Abstract][Full Text] [Related]
18. Sustained prevention of biofilm formation on a novel silicone matrix suitable for medical devices.
Steffensen SL; Vestergaard MH; Groenning M; Alm M; Franzyk H; Nielsen HM
Eur J Pharm Biopharm; 2015 Aug; 94():305-11. PubMed ID: 26028273
[TBL] [Abstract][Full Text] [Related]
19. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
[TBL] [Abstract][Full Text] [Related]
20. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
